Pharma

German Medical Device Manufacturer Invests 90 Million in High-Tech Factory

Erbe equipment used in 20 million procedures annually: Mid-sized company plans further growth.

Eulerpool News May 6, 2024, 5:00 PM

The Swabian medical technology manufacturer Erbe Elektromedizin GmbH continues its expansion and has now inaugurated its new production and development center in Rangendingen. With an investment of 90 million euros, the construction represents the largest single project in the 173-year history of the company, which produces and distributes surgical devices and instruments worldwide. These are used, among other things, for invasive procedures such as lung cancer treatments.

The new facility highlights the company's commitment to strengthening its presence in Germany and investing in the future. "The heart of the company will remain here in Germany, but we need to be much more flexible in the future," explained CEO Christian O. Erbe during the inauguration ceremony. The opening of the Center of Competence was attended by notable guests such as Federal Minister of Finance Christian Lindner and Baden-Württemberg's Minister of Economic Affairs Nicole Hoffmeister-Kraut, who praised Erbe's commitment in the highest terms.

The Company, Which Has Been in Existence Since 1851 and Is Now Led by the Fifth Generation of the Erbe Family, Distinguishes Itself Through Its Specialization in High-Tech Medical Technology. Last Year, Erbe Recorded a 15 Percent Increase in Revenue to 430 Million Euros and Plans to Surpass the Revenue Threshold of One Billion Euros by 2030.

The new facility in Rangendingen is not just a symbolic sign of the innovative strength and economic potential of the German Mittelstand, but also a showcase project in terms of sustainability. It meets the KfW Efficiency House Standard 40 Plus, uses ecological building materials, and is powered by one-third through solar modules installed on the roof. A biogas combined heat and power plant covers the remaining demand.

Despite current challenges such as deindustrialization in Germany and global geopolitical risks, Erbe remains optimistic and is already planning the next expansion of the site to meet high demand. The manufacturing facilities are to be designed modularly and flexibly to be deployed quickly at various locations around the world. This reflects a strategic adjustment to the increasingly volatile global economic situation.

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2

News